Trevi Therapeutics, Inc. (TRVI)
11.14
+0.08
(+0.77%)
USD |
NASDAQ |
Feb 12, 11:00
Trevi Therapeutics Price : 11.14 for Feb. 12, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CorMedix, Inc. | 7.44 |
| Arbutus Biopharma Corp. | 3.93 |
| Bristol Myers Squibb Co. | 60.82 |
| ACADIA Pharmaceuticals, Inc. | 22.17 |
| Alnylam Pharmaceuticals, Inc. | 300.28 |
Price Related Metrics
| Price to Book Value | 7.523 |
| Earnings Yield | -3.33% |
| Market Cap | 1.428B |